ANCA相关性血管炎肾小球肾炎中补体表达的多模态分析及与结局的关联
本研究在369例ANCA相关性血管炎伴肾小球肾炎(AAV-GN)患者中,整合血清补体、肾组织免疫荧光及肾脏转录组数据,发现肾内补体相关转录程序与血清或沉积标志物仅弱相关,且低补体替代途径表达与更好的肾脏及总体生存独立相关。
要点
- 血清C3降低与更严重肾脏受累、肾衰竭及死亡风险独立相关。
- 肾小球C3和C1q沉积提示更严重病理及不良结局。
- 肾内补体转录程序仅弱反映血清或免疫荧光标志物。
核心结论
- AAV-GN存在可重复的肾内补体相关转录程序,常规血清或免疫荧光标志物仅能弱捕捉该程序,且其与肾脏严重程度及结局相关。
研究设计与样本
- 两项独立回顾性队列共纳入369例AAV-GN患者,评估血清C3/C4、肾小球C1q/C3沉积及靶向肾脏转录组,并利用公共空间转录组数据验证。
主要发现
- 血清C3低于正常水平不常见;低血清C3(而非C4)与更严重肾脏受累、肾衰竭(aHR 2.0 [1.1-3.7])及死亡(aHR 2.3 [1.3-4.0])相关。
- 肾小球C3沉积占47%、C1q沉积占11%,两者均提示更严重病理及不良结局。
- 与对照相比,AAV-GN肾脏补体相关表达增加,包括经典途径成分、近端替代途径基因(C3、C5AR1)及调节转录本,但与血清或沉积标志物仅弱一致。
- 低替代途径相关表达与更好的肾脏生存(aHR 0.3 [0.1-0.7])及总体生存(aHR 0.4 [0.2-0.9])独立相关。
- 空间转录组验证上述特征,并提示免疫细胞与肾脏固有细胞均参与贡献。
临床怎么用
- 血清C3降低可辅助识别AAV-GN中肾脏受累更重、预后更差的患者。
- 肾小球C3或C1q沉积阳性提示更严重病理及不良结局,应加强监测。
- 肾内补体转录组有望用于风险分层及治疗假设生成,但尚需前瞻性研究验证。
局限性
- 回顾性队列设计可能引入选择偏倚。
- 常规血清及免疫荧光标志物仅弱反映肾内补体转录程序,限制其替代价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with glomerulonephritis (AAV-GN) is classically considered pauci-immune, yet complement activation is a central pathogenic mechanism. Whether intrarenal complement-related transcriptional programs are reflected by conventional serum or immunofluorescence markers, and whether they are clinically informative, remains unclear. METHODS: In 369 patients with AAV-GN from 2 independent retrospective cohorts, complement was assessed across circulating, histopathologic, and transcriptomic layers (serum C3/C4, glomerular C1q/C3 deposition, and targeted kidney transcriptomics). Predefined classical and alternative pathway-related expression scores were derived from intrarenal gene expression. Associations with severity and outcomes were evaluated using multivariable Cox models. Public spatial transcriptomic data sets provided validation and localization. RESULTS: Below-normal serum C3/C4 levels were uncommon. Low serum C3, but not C4, was associated with more severe kidney involvement, kidney failure (adjusted hazard ratio [aHR]: 2.0 [1.1-3.7]), and mortality (aHR: 2.3 [1.3-4.0]). Both glomerular C3 (47%) and C1q (11%) deposition identified more severe pathology and adverse outcomes. Compared with controls, AAV-GN kidneys showed increased complement-related expression-including classical pathway components, proximal alternative pathway genes (C3, C5AR1), and regulatory transcripts-that was only weakly concordant with serum or deposition markers. Low alternative pathway-related expression was independently associated with better kidney (aHR: 0.3 [0.1-0.7]) and overall (aHR: 0.4 [0.2-0.9]) survival. Spatial transcriptomics validated these signatures and suggested contributions from both immune and resident kidney compartments. CONCLUSION: AAV-GN displays a reproducible intrarenal complement-related transcriptional program, only weakly captured by serum levels or routine immunofluorescence, associated with renal severity and outcomes. These findings support prospective studies integrating tissue complement transcriptomics for stratification and therapeutic hypothesis generation.
引用
- Brilland B, Milon V, Vandenbussche C, et al. Multimodal Profiling of Complement Expression and Association With Outcomes in ANCA-Associated Vasculitis With Glomerulonephritis. Kidney Int Rep. 2026. PMID: 42866688. doi:10.1016/j.ekir.2026.107056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。